SG Americas Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,510,712
Closed -$241M 3506
2025
Q4
$241M Buy
2,510,712
+2,402,600
+2,222% +$233M 0.31% 43
2025
Q3
$10.3M Sell
108,112
-610,632
-85% -$56.1M 0.03% 312
2025
Q2
$62.7M Sell
718,744
-561,888
-44% -$47.7M 0.26% 56
2025
Q1
$115M Buy
1,280,632
+1,279,124
+84,823% +$114M 0.38% 32
2024
Q4
$120K Sell
1,508
-24,952
-94% -$2.16M ﹤0.01% 2602
2024
Q3
$2.38M Sell
26,460
-207,533
-89% -$17.5M 0.01% 613
2024
Q2
$18.4M Sell
233,993
-103,673
-31% -$8.5M 0.11% 188
2024
Q1
$29.4M Sell
337,666
-7,647
-2% -$653K 0.14% 152
2023
Q4
$28.4M Buy
345,313
+304,496
+746% +$23.2M 0.27% 77
2023
Q3
$3.2M Sell
40,817
-48,889
-54% -$4.09M 0.04% 476
2023
Q2
$7.9M Buy
89,706
+64,821
+260% +$5.58M 0.06% 230
2023
Q1
$2.01M Sell
24,885
-70,854
-74% -$5.77M 0.02% 657
2022
Q4
$7.44M Buy
95,739
+2,904
+3% +$235K 0.09% 180
2022
Q3
$7.5M Sell
92,835
-76,893
-45% -$6.91M 0.09% 190
2022
Q2
$15.2M Sell
169,728
-1,594,120
-90% -$162M 0.16% 101
2022
Q1
$196M Buy
1,763,848
+1,536,417
+676% +$162M 1.44% 9
2021
Q4
$23.5M Sell
227,431
-28,622
-11% -$3.31M 0.13% 114
2021
Q3
$32.1M Sell
256,053
-25,511
-9% -$3.3M 0.15% 81
2021
Q2
$35M Sell
281,564
-159,302
-36% -$20M 0.16% 107
2021
Q1
$52.1M Buy
440,866
+167,072
+61% +$19.6M 0.27% 62
2020
Q4
$32.1M Buy
273,794
+259,487
+1,814% +$28.6M 0.17% 94
2020
Q3
$1.49M Sell
14,307
-157,838
-92% -$15.9M 0.01% 945
2020
Q2
$15.8M Sell
172,145
-154,911
-47% -$14.9M 0.13% 122
2020
Q1
$29.5M Sell
327,056
-76,974
-19% -$8.19M 0.28% 59
2019
Q4
$45.8M Sell
404,030
-84,316
-17% -$9.25M 0.42% 34
2019
Q3
$53M Sell
488,346
-294,408
-38% -$30.7M 0.44% 32
2019
Q2
$76.2M Buy
782,754
+297,669
+61% +$27.2M 0.53% 27
2019
Q1
$44.2M Sell
485,085
-131,675
-21% -$11.8M 0.41% 33
2018
Q4
$56.1M Buy
616,760
+163,458
+36% +$15.3M 0.49% 32
2018
Q3
$44.6M Buy
453,302
+214,471
+90% +$19.8M 0.33% 49
2018
Q2
$20.4M Buy
238,831
+4,472
+2% +$374K 0.18% 107
2018
Q1
$18.8M Sell
234,359
-96,046
-29% -$7.92M 0.15% 115
2017
Q4
$26.7M Buy
330,405
+195,245
+144% +$15.6M 0.25% 56
2017
Q3
$10.5M Sell
135,160
-307,251
-69% -$25.5M 0.09% 156
2017
Q2
$39.3M Buy
442,411
+204,604
+86% +$17.3M 0.35% 50
2017
Q1
$19.2M Sell
237,807
-118,212
-33% -$9.23M 0.17% 108
2016
Q4
$25.4M Buy
356,019
+289,874
+438% +$22.8M 0.21% 91
2016
Q3
$5.71M Buy
66,145
+8,103
+14% +$706K 0.06% 306
2016
Q2
$5.04M Sell
58,042
-81,980
-59% -$6.63M 0.04% 393
2016
Q1
$10.5M Buy
140,022
+81,951
+141% +$6.17M 0.08% 203
2015
Q4
$4.47M Sell
58,071
-518,954
-90% -$39.1M 0.03% 421
2015
Q3
$6.48M Buy
577,025
+398,744
+224% +$29.4M 0.04% 312
2015
Q2
$13.2M Sell
178,281
-54,377
-23% -$4.15M 0.09% 164
2015
Q1
$18.1M Sell
232,658
-225,232
-49% -$17.1M 0.11% 150
2014
Q4
$33.1M Buy
457,890
+200,542
+78% +$13.9M 0.16% 114
2014
Q3
$15.9M Buy
257,348
+29,264
+13% +$1.86M 0.09% 222
2014
Q2
$14.5M Sell
228,084
-980,308
-81% -$59.6M 0.08% 239
2014
Q1
$74.4M Buy
1,208,392
+405,222
+50% +$23.6M 0.32% 64
2013
Q4
$46.1M Buy
803,170
+297,214
+59% +$16.9M 0.19% 115
2013
Q3
$26.9M Sell
505,956
-406,667
-45% -$21.9M 0.11% 182
2013
Q2
$47M Buy
+912,623
New +$45.1M 0.23% 89

Other funds holding MDT

SG Americas Securities's MDT Position: Q1 2026 in Review

SG Americas Securities sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,510,712 shares — an estimated $241M sold.

SG Americas Securities first reported a position in MDT in Q2 2013 and held it in 51 quarters. The position peaked at $241M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • SG Americas Securities reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 2,510,712 Medtronic shares in Q1 2026, an estimated $241M.
  • SG Americas Securities first reported a position in Medtronic in Q2 2013 and held it in 51 quarters.
  • SG Americas Securities's Medtronic position peaked at $241M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.